Newsbenzinga
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results
· Published
Article summary
Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. Analysts have a positive outlook on ABT stock.
An excerpt from the original article.
Comments —
Loading comments…